Original Research

Screening Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Patients After Tyrosine Kinase Inhibitor Plus PD-1/PD-L1 Antibody Therapy: A Multicenter Retrospective Study

Jin Z, Li X, Lv L, Zhang B, Ma X, Chen S, You J, Wu X, Wang L, Liu X, Wang F, Chen X, Yu L, Zhang S, Zhang L

Journal of Hepatocellular Carcinoma 2025, 12:1921-1941

Published Date: 25 August 2025